Stocks to sell

Canopy Growth (NYSE:CGC), with a $6.5 billion market capitalization, and 2.7 billion CAD in cash, remains better positioned than most of its peers. Source: Shutterstock Nonetheless, like most other marijuana equities, it continues in a downtrend. Worse, little on the horizon has appeared that could keep Canopy around. This decline could bring a grim scenario

After falling to prices as low as $1.19 per share, Nio (NYSE:NIO) stock is rebounding. And after reporting higher than expected deliveries, and launching a new partnership with Intel’s (NASDAQ:INTC) Mobileye, the Chinese electric vehicle (EV) startup appears to be better positioned. Source: Sundry Photography / Shutterstock.com The Nio stock price has jumped over 100%

It’s been a good month for General Electric (NYSE:GE). Thanks to a strong third-quarter earnings report, the GE stock price touched a 52-week high. And General Electric stock could rise further going forward if the company can deliver on its potential. Source: Jonathan Weiss / Shutterstock.com There are two problems with that “if.” First,  General

Shares of Twitter (NYSE:TWTR) plunged in late October from above $40 to below $30 after the social media company reported lousy third quarter numbers and delivered an even-lousier fourth quarter guide, the sum of which sparked concerns that elevated competition in the digital ad market was materially shrinking the company’s growth trajectory. Source: Worawee Meepian

If you were investing in industrials stocks for the last 18 months, then you know it has been a bumpy ride. Some very solid companies are being affected by many factors that can be summarized under the broad category of “slowing economic growth.” It’s not a secret that there has been a global manufacturing downturn.

As it pierces through its previous high-water mark set in April, Lowe’s Companies (NYSE:LOW) stock seems to be demonstrating the resilience of some (though certainly not all) brick-and-mortar retailers in the face of the disruptive Amazon (NASDAQ:AMZN) threat. Source: Helen89 / Shutterstock.com With this encouraging price action comes a caveat, though, as recent store closings

U.S. equities are pushing to new record highs this week thanks to more indications that a Phase One trade deal between the United States and China is forthcoming. A number of big M&A deals have bolstered sentiment as well, including a $26 billion deal by Charles Schwab (NYSE:SCHW) to buy TD Ameritrade (NASDAQ:AMTD) and a

The bull market in stocks has now transpired for more than ten years. Although stocks to sell exist in almost any market environment, such a run will naturally leave some overvalued equities. This had led to investors turning on some once-beloved companies. Also, in recent years, the market has seen many IPOs launch. While some

Autumn has been kind to Intel (NASDAQ:INTC).  Since bottoming out at $44.55 in September, INTC stock rallied to a high of nearly $59 a share.  All thanks to a solid earnings beat. Source: dennizn / Shutterstock.com Earnings of $1.42 per share crushed expectations for $1.24.  Revenue of $19.19 billion trounced $18.05 billion expectations.  It even

I have maintained a “Bearish” view on most of the cannabis stocks in the last few months. My view has been backed by factors of cash burn, lack of clinical research and regulatory hurdles for industry players. There are still no compelling reasons to consider exposure to Aurora Cannabis (NYSE:ACB), even with ACB stock sliding

For the better part of the past five years, Salesforce (NYSE:CRM) has been a big growth, cloud-based Customer Relationship Management (or CRM) company with improving margins and a stock price that has surged higher. Because of this, Salesforce stock has been a favorite among Wall Street analysts and investors alike. Source: Bjorn Bakstad / Shutterstock.com But,

The woes continue for Aurora Cannabis (NYSE:ACB). ACB stock continues to fall as concerns increase about the financial health of the company. The early bet the company made on capacity has deeply hurt the company as sales fall alarmingly short of production levels. Source: ElRoi / Shutterstock.com As a result, investors have begun to balk

If there is any business that you’d think would be an easy buck, it would be marijuana. A year ago, the march toward legalization looked like the end of liquor prohibition in the United States, great for those licensed to produce the stuff, but the end to fat profits for those with inferior weed. Source:

Although Blue Apron (NASDAQ:APRN) had a typical IPO, Blue Apron stock didn’t. Source: Roman Tiraspolsky / Shutterstock.com The IPO market often struggles with over-hype issues. That is, a new and exciting company often IPOs on the public markets with a splash, and investors gobble up the shares at a premium price under the expectation that

Tilray (NASDAQ:TLRY) stock, like other marijuana companies, rallied massively last week. The chances of  marijuana being legalized in the U.S. increased a little last week after the House of Representatives’ Judiciary Committee approved a bill that would lift the federal government’s restrictions on the drug. Of course,  if the bill becomes law,  Tilray stock and

If you own Hexo (NYSE:HEXO) stock, you’re probably wondering if it can get any worse. Hexo’s share price was recently down 80% from its April peak. Just since the beginning of October, HEXO stock had lost more than half of its remaining value. Shares recently tanked below the $2 mark following lousy earnings both at

If we can be sure of one thing in 2019, it’s that not all stocks are created equal. We have seen  sectors rise and some of the big names falter all the same. This has certainly been a stock picker’s market. And I say that knowing full well that the S&P 500 is up an

Cannabis companies have seen their stock prices go up in a puff of smoke in 2019. Investors have grown weary of waiting on profits. Which makes the current decline in Aphria (NYSE:APHA) stock a little bemusing. In its most recent earnings report, APHA actually recorded a profit, albeit a slight one. The company reported positive

Cannabis stocks have been crushed, but are they now coming back to life? Down 68% year-to-date but up some 20% over the past few days, Tilray (NASDAQ:TLRY) seems to fit that description. However, Tilray stock isn’t necessarily the one that investors should be banking on. Source: Jarretera / Shutterstock.com Earlier this week, there was some

Google parent Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) is one of the largest, most widely followed companies in the market. On Oct. 28, GOOGL  released third-quarter earnings that failed to impress analysts. Yet Alphabet stock is still up about 24% in 2019. Source: rvlsoft / Shutterstock.com In my opinion, it’s not an opportunistic time for long-term investors to buy Google